Home › Funds › COOKE & BIELER LP › CRL

COOKE & BIELER LP position in CRL

CHARLES RIV LABS INTL INC · Health Care

COOKE & BIELER LP reported holding 432,121 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$127.5M, representing 2.01% of its reported portfolio and ranking #13 among its reported holdings. COOKE & BIELER LP has disclosed CRL holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)432.12K sh
Reported value held$127.48M
Portfolio Weight2.01%
First reportedQ3 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How COOKE & BIELER LP's CRL position evolved

COOKE & BIELER LP first disclosed a stake in CRL in Q3 2024 at 300,395 shares (US$59.2M). The position peaked in Q2 2026 at 755,630 shares, worth US$171.4M. Across 9 filings, COOKE & BIELER LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 432,121 shares valued at US$127.5M — a reduction of -323,509 shares quarter over quarter.. Notable position changes include a 43% increase in Q2 2025 (shares rose 3% over the following quarter), a 43% increase in Q1 2026 (shares rose 31% over the following quarter), a 43% trim in Q3 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 300.39K $59.17M New
Q4 2024 426.77K $78.78M Add
Q1 2025 419.64K $63.16M Reduce
Q2 2025 598.78K $90.85M Add
Q3 2025 603.88K $94.48M Add
Q4 2025 607.57K $121.20M Add
Q1 2026 867.92K $149.72M Add
Q2 2026 755.63K $171.37M Reduce
Q3 2026 432.12K $127.48M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 28 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has COOKE & BIELER LP held CRL?

COOKE & BIELER LP has disclosed CRL holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is COOKE & BIELER LP's current position in CRL?

As of Q3 2026, COOKE & BIELER LP holds 432.12K shares of CRL (CHARLES RIV LABS INTL INC), valued at $127.48M, representing 2.01% of its reported portfolio and ranking #13.

Has COOKE & BIELER LP been buying or selling CRL?

In the latest 13F filing (Q3 2026), COOKE & BIELER LP reduced its position in CRL. The position peaked in Q2 2026 at 755.63K shares.

Which other funds hold CRL?

Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.